Combination of adefovir dipivoxil with lamivudine vs. adefovir alone in lamivudine-resistant HBeAg-negative chronic hepatitis B patients

被引：0
|
作者：
Rapti, Irene N.
Dimou, Evangelini
Mitsoula, Panayota
Hadziyannis, Stephanos J.
机构：
[1] Henry Dunant Hosp, Liver Unit, Athens, Greece
[2] Univ Athens, Evgenidion Hosp, Hepatitis Res Lab, Athens, Greece
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
994
引用
收藏
页码：558A / 559A
页数：2
相关论文
共 50 条
  • [21] How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?
    Jurriën GP Reijnders
    Harry LA Janssen
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 : 668 - 669
  • [22] Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
    Yeon, J. E.
    Yoo, W.
    Hong, S. P.
    Chang, Y. J.
    Yu, S. K.
    Kim, J. H.
    Seo, Y. S.
    Chung, H. J.
    Moon, M. S.
    Kim, S-O
    Byun, K. S.
    Lee, C. H.
    [J]. GUT, 2006, 55 (10) : 1488 - 1495
  • [23] Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
    Vincent Lai
    David Mutimer
    Darius Mirza
    [J]. Hepatobiliary & Pancreatic Diseases International, 2006, (01) : 154 - 156
  • [24] How effective is adefovir dipivoxil plus lamivudine for the treatment of lamivudine-resistant chronic hepatitis B?
    Reijnders, Jurrien G. P.
    Janssen, Harry L. A.
    [J]. NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2008, 5 (12): : 668 - 669
  • [25] Importance of Serum Concentration of Adefovir for Lamivudine-Adefovir Combination Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B
    Mitsui, Fukiko
    Tsuge, Masataka
    Kimura, Takashi
    Kitamura, Shosuke
    Abe, Hiromi
    Saneto, Hiromi
    Kawaoka, Tomokazu
    Miki, Daiki
    Hatakeyama, Tsuyoshi
    Hiraga, Nobuhiko
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Takahashi, Shoichi
    Hayes, C. Nelson
    Igarashi, Harue
    Morimoto, Kentaro
    Shimizu, Masao
    Chayama, Kazuaki
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (08) : 3205 - 3211
  • [26] Lamivudine and Adefovir Combination Therapy in Lamivudine Resistant HBeAg Positive Chronic Hepatitis B Patients
    Lee, H. S.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A190 - A190
  • [27] Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
    Ahn, Sang-Hoon
    Kweon, Young-Oh
    Paik, Seung-Woon
    Sohn, Joo-Hyun
    Lee, Kwan-Sik
    Kim, Dong Joon
    Piratvisuth, Teerha
    Yuen, Man Fung
    Chutaputti, Anuchit
    Chao, You-Chen
    Trylesinski, Aldo
    Avila, Claudio
    [J]. HEPATOLOGY INTERNATIONAL, 2012, 6 (04) : 696 - 706
  • [28] Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
    Sang-Hoon Ahn
    Young-Oh Kweon
    Seung-Woon Paik
    Joo-Hyun Sohn
    Kwan-Sik Lee
    Dong Joon Kim
    Teerha Piratvisuth
    Man Fung Yuen
    Anuchit Chutaputti
    You-Chen Chao
    Aldo Trylesinski
    Claudio Avila
    [J]. Hepatology International, 2012, 6 : 696 - 706
  • [29] Short-term overlap lamivudine treatment with adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B
    Nam, Soon Woo
    Bae, Si Hyun
    Lee, Seung Woo
    Kim, Yeon Soo
    Kang, Sang Bum
    Choi, Long Young
    Cho, Se Hyun
    Ybon, Seung Kew
    Han, Joon-Yeol
    Yang, Jin Mo
    Lee, Young Suk
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (11) : 1781 - 1784
  • [30] Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
    Buti, M
    Casado, MA
    Calleja, JL
    Salmerón, J
    Aguilar, J
    Rueda, M
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 409 - 419
12345